The tert-butyl dimethyl silyl group as an enhancer of drug cytotoxicity against human tumor cells

Bioorg Med Chem Lett. 2005 Aug 1;15(15):3536-9. doi: 10.1016/j.bmcl.2005.05.126.

Abstract

In this study, we synthesized a series of enantiomerically pure (2R,3S)-disubstituted tetrahydropyranes with diverse functional groups using known methodologies. In addition to the tert-butyl dimethyl silyl group, other common protecting groups for hydroxyl groups such as allyl, acetate, and benzoate were used to obtain appropriate derivatives. Pure compounds were evaluated in vitro against HL60 human leukemia cells and MCF7 human breast cancer cells. From the growth inhibition data a structure-activity relationship was obtained. Overall the results point to the relevant role of the tert-butyl dimethyl silyl group in the modulation of cytotoxic activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetates / chemistry
  • Allyl Compounds / chemistry
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / pharmacology*
  • Benzoates / chemistry
  • Breast Neoplasms / pathology
  • Cell Proliferation / drug effects
  • Drug Screening Assays, Antitumor
  • Humans
  • Leukemia / pathology
  • Organosilicon Compounds / chemical synthesis
  • Organosilicon Compounds / pharmacology*
  • Pharmaceutical Preparations
  • Pyrans / chemical synthesis
  • Pyrans / pharmacology*
  • Structure-Activity Relationship
  • Tumor Cells, Cultured

Substances

  • Acetates
  • Allyl Compounds
  • Antineoplastic Agents
  • Benzoates
  • Organosilicon Compounds
  • Pharmaceutical Preparations
  • Pyrans
  • t-butyldimethylsilyl compounds